UBS O'Connor’s Sanofi SNY Stock Holding History

UBS O'Connor’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,000	Closed	-$20.3K	–	563
2024 Q3	$20.3K	Sell	15,000 -15,000	-50%	-$810K	﹤0.01%	446
2024 Q2	$22.5K	Buy	+30,000	New	+$1.45M	﹤0.01%	476

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS O'Connor's SNY Position: Q4 2024 in Review

UBS O'Connor sold out of Sanofi (SNY) in Q4 2024, closing a stake of 34,144 shares — an estimated $1.97M sold.

UBS O'Connor first reported a position in SNY in Q2 2022 and held it in 9 quarters. The position peaked at $6.14M in Q4 2023. 731 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

UBS O'Connor reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
UBS O'Connor sold 34,144 Sanofi shares in Q4 2024, an estimated $1.97M.
UBS O'Connor first reported a position in Sanofi in Q2 2022 and held it in 9 quarters.
UBS O'Connor's Sanofi position peaked at $6.14M in Q4 2023.
731 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.